Mettler-Toledo International (NYSE:MTD) & Stevanato Group (NYSE:STVN) Head-To-Head Comparison

Stevanato Group (NYSE:STVN – Get Free Report) and Mettler-Toledo International (NYSE:MTD – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Analyst Ratings

This is a summary of current ratings for Stevanato Group and Mettler-Toledo International, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group 0 5 2 2 2.67
Mettler-Toledo International 1 8 6 0 2.33

Mettler-Toledo International has a consensus price target of $1,595.77, indicating a potential downside of 4.30%. Given Mettler-Toledo International’s higher probable upside, analysts plainly believe Mettler-Toledo International is more favorable than Stevanato Group.

Profitability

This table compares Stevanato Group and Mettler-Toledo International’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Stevanato Group 11.24% 10.51% 6.22%
Mettler-Toledo International 22.25% 15,012.71% 25.41%

Earnings & Valuation

This table compares Stevanato Group and Mettler-Toledo International”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Stevanato Group $1.34 billion 3.55 $158.21 million €0.58 27.09
Mettler-Toledo International $4.03 billion 8.24 $869.19 million $46.15 36.13

Mettler-Toledo International has higher revenue and earnings than Stevanato Group. Stevanato Group is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Stevanato Group has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500.

Institutional & Insider Ownership

95.1% of Mettler-Toledo International shares are owned by institutional investors. 0.7% of Stevanato Group shares are owned by insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Mettler-Toledo International beats Stevanato Group on 13 of the 15 factors compared between the two stocks.

About Stevanato Group

(Get Free Report)

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.

About Mettler-Toledo International

(Get Free Report)

Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes. The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.